The ideal candidate will bring strong experience leading complex early-phase clinical trials, particularly first-in-human studies, with experience in one or more relevant therapeutic areas such as autoimmune or immune-mediated disease, immuno-oncology/oncology, neuroimmunology/multiple sclerosis, cell therapy/CAR-T, gene therapy, or other advanced therapeutic modalities. Lead and oversee execution of first-in-human through phase 4 trials, depending on lifecycle of program, in compliance with ICH/GCP, local regulations, and Moderna SOPs, with particular emphasis on the operational complexities associated with early clinical development, first-in-human studies and autoimmune studies.